EZH2 was found essential for the proliferation of breast cancer type I susceptibility protein BRCA1-/- cells [161], while EZH2 overexpression in breast cancer is associated with poor prognosis and correlates with metastatic sporadic and familial breast tumours [160,162]. This evidence concerns the gene EZH2 and breast carcinoma.